An Update on Orthobiologics: Cautious Optimism.

Am J Sports Med · Jan 2024 · Review

Nelson PA, George T, Bowen E, Sheean AJ, Bedi A

Northshore University Healthcare System, Evanston, Illinois

Sports Medicine

SUMMARY — THE REDUCTIONThis review summarizes the current state of orthobiologics such as PRP and stem cells, noting their growing use but limited high-quality evidence and inconsistent nomenclature, warranting cautious optimism.
Abstract, as published

Orthobiologics are rapidly growing in use given their potential to augment healing for multiple musculoskeletal conditions. Orthobiologics consist of a variety of treatments including platelet-rich plasma and stem cells that provide conceptual appeal in providing local delivery of growth factors and inflammation modulation. The lack of standardization in nomenclature and applications within the literature has led to a paucity of high-quality evidence to support their frequent use. The purpose of this review was to describe the current landscape of orthobiologics and the most recent evidence regarding their use.

Featured in the 2026-10-10 issue.

← Outcome of lower trapezius transfer to reconstruct massive ir…Rotator Cuff Consensus Part III: Reverse Total Shoulder Arthr… →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.